Board to consider raising funds via NCDs on Oct 12

Fund Raising View source PDF Explain this filing

JUBLPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-3.7%Reaction day

₹975.00

prior close

₹971.00

announcement price

After-mkt

timing

Nifty Microcap 250market-2.8%-0.9% vs market

Pharmaceuticals peers, median of 172sector-2.4%-1.2% vs sector

On the reaction day the stock moved 0.9 pts less than Nifty Microcap 250 and 1.2 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.0

10m

-1.5

15m

-1.4

30m

-2.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-3.7-2.8-0.9-2.4-1.2

Next day

-4.6-2.5-2.1-2.6-2.0

-1.0-1.7+0.6-2.5+1.5

-2.6-1.5-1.1-2.5-0.1

-4.1-0.8-3.3-2.5-1.6

-4.3-2.4-1.8-3.2-1.1

-3.3-3.4+0.0-4.4+1.1

15d

———-4.8—

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 172Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Jubilant Pharmova's board will meet on Monday, October 12, 2026, to consider and approve raising of funds through the issuance of Non-Convertible Debentures (NCDs) and/or other permitted securities. The company will also seek shareholder approval as required. No details on the issue size, coupon rate, or tenure have been disclosed yet.

Likely market impact

Could expand the company's debt load. Watch for NCD size, pricing, and use of funds after the board meeting on Oct 12.